中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
24期
146-148
,共3页
曲美他嗪%老年患者%冠心病%充血性心力衰竭%肌钙蛋白
麯美他嗪%老年患者%冠心病%充血性心力衰竭%肌鈣蛋白
곡미타진%노년환자%관심병%충혈성심력쇠갈%기개단백
Trimetazidine%Senile patients%Coronary heart disease%Congestive heart failure%Troponin
目的:探讨曲美他嗪对老年冠心病合并充血性心力衰竭患者肌钙蛋白水平的影响。方法本研究选取2012年1月~2014年12月我院收治的110例老年冠心病合并充血性心力衰竭患者作为研究对象,将110例患者随机分为对照组和观察组,每组各55例,对照组患者采用常规治疗,观察组患者在对照组治疗的基础上加用曲美他嗪治疗,对比两组患者的临床疗效。结果对照组患者的治疗总有效率为70.9%;观察组患者的治疗总有效率为89.1%,与对照组相比,观察组患者的治疗总有效率明显提高(P<0.05)。在治疗后,与对照组相比,观察组患者的肌钙蛋白水平明显降低(P<0.05)。结论曲美他嗪治疗老年冠心病合并充血性心力衰竭的有效率高,且能降低患者的肌钙蛋白水平。
目的:探討麯美他嗪對老年冠心病閤併充血性心力衰竭患者肌鈣蛋白水平的影響。方法本研究選取2012年1月~2014年12月我院收治的110例老年冠心病閤併充血性心力衰竭患者作為研究對象,將110例患者隨機分為對照組和觀察組,每組各55例,對照組患者採用常規治療,觀察組患者在對照組治療的基礎上加用麯美他嗪治療,對比兩組患者的臨床療效。結果對照組患者的治療總有效率為70.9%;觀察組患者的治療總有效率為89.1%,與對照組相比,觀察組患者的治療總有效率明顯提高(P<0.05)。在治療後,與對照組相比,觀察組患者的肌鈣蛋白水平明顯降低(P<0.05)。結論麯美他嗪治療老年冠心病閤併充血性心力衰竭的有效率高,且能降低患者的肌鈣蛋白水平。
목적:탐토곡미타진대노년관심병합병충혈성심력쇠갈환자기개단백수평적영향。방법본연구선취2012년1월~2014년12월아원수치적110례노년관심병합병충혈성심력쇠갈환자작위연구대상,장110례환자수궤분위대조조화관찰조,매조각55례,대조조환자채용상규치료,관찰조환자재대조조치료적기출상가용곡미타진치료,대비량조환자적림상료효。결과대조조환자적치료총유효솔위70.9%;관찰조환자적치료총유효솔위89.1%,여대조조상비,관찰조환자적치료총유효솔명현제고(P<0.05)。재치료후,여대조조상비,관찰조환자적기개단백수평명현강저(P<0.05)。결론곡미타진치료노년관심병합병충혈성심력쇠갈적유효솔고,차능강저환자적기개단백수평。
Objective To investigate the effect trimetazidine on troponin levels for senile patients with coronary heart disease and congestive heart failure. Methods 110 cases of senile patients with coronary heart disease and congestive heart failure were selected from January 2012 to December 2014 in our hospital as the research subjects, 110 patients were randomly divided into control group and observation group, 55 cases in each group, the control group were treated with conventional therapy, the observation group were treated with conventional therapy and Trimetazidine therapy, the clinical effect of two groups was contrasted. Results The total effective rate of control group and observation group was 70.9%and 89.1%respectively, compared with the control group, the total effective rate of the observation group was improved signiifcantly (P<0.05). After the treatment,compared with the control group,the troponin levels of observation group was signiifcantly lower (P<0.05). Conclusion Trimetazidine applies to the senile patients with coronary heart disease and congestive heart failure has a high efifciency, and it can signiifcantly reduce troponin levels in patients.